Anbio Biotechnology (NASDAQ:NNNN) Shares Gap Down – Should You Sell?

Anbio Biotechnology (NASDAQ:NNNN)’s share price gapped down before the market opened on Friday . The stock had previously closed at $22.54, but opened at $21.51. Anbio Biotechnology shares last traded at $21.6190, with a volume of 11,484 shares traded.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings upgraded shares of Anbio Biotechnology from a “sell (d+)” rating to a “hold (c-)” rating in a report on Monday, February 9th. One equities research analyst has rated the stock with a Hold rating, According to MarketBeat, the stock has a consensus rating of “Hold”.

Anbio Biotechnology Trading Down 9.0%

Anbio Biotechnology (NASDAQ:NNNN) last issued its quarterly earnings results on Tuesday, December 30th. The company reported $0.04 earnings per share for the quarter. The business had revenue of $2.29 million during the quarter.

About Anbio Biotechnology

Anbio Biotechnology is dedicated to the advancement of medical technology and the provision of in vitro diagnostics (IVD) products. Our unwavering commitment lies in transforming the diagnostics landscape on a global scale, fostering a paradigm shift towards personalized and decentralized diagnostic solutions. By doing so, we aim to significantly enhance patient prognosis and contribute to the betterment of healthcare worldwide. At Anbio Biotechnology, our extensive portfolio comprises an array of IVD products designed to cater to diverse diagnostic needs.